China Carves Niche in Pharma Outsourcing

In drug discovery services for global Big Pharma, the mainland has the potential to thrive like India has in software outsourcing

With America caught up in a credit crunch causing the subprime lending crisis, August didn't seem a particularly good month to list on the New York Stock Exchange. No one told this to Wuxi Pharmatech, a Shanghai-based pharmaceuticals and biotechnology firm.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.